63. Idiopathic thrombocytopenic purpura Clinical trials / Disease details

Clinical trials : 363 / Drugs : 212 - (DrugBank : 43) / Drug target genes : 47 - Drug target pathways : 138

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03222843 (ClinicalTrials.gov)	June 30, 2017	18/7/2017	Multicentre, Randomised Phase III Study of the Efficacy and Safety of Hetrombopag Olamine in Idiopathic Thrombocytopenic Purpura (ITP) Patient	A Phase III,Multicentre, Randomized, Double-Blind and Open-Label Study to Evaluate the Safety and Efficacy of Hetrombopag Olamine in Patients With Idiopathic Thrombocytopenic Purpura	Idiopathic Thrombocytopenic Purpura	Drug: Hetrombopag Olamine;Drug: matching placebo	Jiangsu HengRui Medicine Co., Ltd.	NULL	Recruiting	18 Years	N/A	All	414	Phase 3	China
2	NCT02614846 (ClinicalTrials.gov)	August 2015	19/11/2015	Safety and Efficacy Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients	A Safety, Pharmacokinetics and Pharmacodynamics Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura	Chronic Idiopathic Thrombocytopenic Purpura	Drug: Hetrombopag Olamine	Jiangsu HengRui Medicine Co., Ltd.	NULL	Recruiting	18 Years	65 Years	Both	29	Phase 1	China
3	NCT02403440 (ClinicalTrials.gov)	April 2014	20/3/2015	A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients	A Safety, Pharmacokinetics and Pharmacodynamics Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura	Purpura, Thrombocytopenic, Idiopathic	Drug: Hetrombopag Olamine	Jiangsu HengRui Medicine Co., Ltd.	NULL	Recruiting	18 Years	65 Years	Both	24	Phase 1	China